SCHEMBL4986746

SCHEMBL4986746

NC(=O)c1n[c]c2c(n1)CN(Cc1c(F)cccc1Cl)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
TDP1 Q9NUW8 2/20 0.44
ALOX15 P16050 1/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
C5AR1 P21730 1/20 0.42
CYP2A13 Q16696 1/20 0.41
COMT P21964 1/20 0.41
KDM4E B2RXH2 3/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GRM2 Q14416 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CACNA1G O43497 4/20 0.39
KCNH2 Q12809 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988672 0.82 GRM2 (0.43) GRM2
SCHEMBL4988549 0.81 GRM2 (0.43) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL4984714 0.81 KMT2A (0.44) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL4992359 0.80 MEN1 (0.41) MEN1KMT2APOLBGRM2
SCHEMBL4993338 0.80 CLPP (0.42) MEN1KMT2AKDM4ESMN1; SMN2GRM2
SCHEMBL4988838 0.80 GRM2 (0.47) ALDH1A1ALOX15MEN1KMT2AKDM4E
SCHEMBL4991104 0.80 GRM2 (0.42) ALDH1A1TDP1KDM4ESMN1; SMN2GRM2
SCHEMBL4986113 0.79 MAPK14 (0.45) TDP1L3MBTL1LMNA
SCHEMBL4984837 0.79 CCR2 (0.41) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL4982983 0.78 GRM2 (0.41) C5AR1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 ALDH1A1 3640/4885TDP1 2440/4885ALOX15 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.